SHARON KOEHLER: Open Payments
NPI 1366162232 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 22 payments from 12 companies in 2025. Trend: 2023 $184 · 2024 $325 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 6 | $163 |
| ABBVIE INC. | 4 | $85 |
| TG Therapeutics, Inc. | 2 | $75 |
| Janssen Biotech, Inc. | 1 | $61 |
| EMD Serono, Inc. | 2 | $44 |
| GENZYME CORPORATION | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Eisai Inc. | 1 | $23 |
| SK Life Science, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: NUPLAZID, BRIUMVI, BOTOX, ACTHAR, Leqembi, QULIPTA, VYALEV, UBRELVY.
Industry payments across NE — which companies pay providers there.
